miR‐134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non‐small cell lung cancer cells

By  

FEBS Open Bio, Vol. 586, Iss. 20, 2012-10 ,pp. : 3761-3765

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells

By Guo Haizhou   Li Qianping   Li Weihao   Zheng Tianliang   Zhao Song   Liu Zhangsuo  

Molecular and Cellular Biochemistry, Vol. 390, Iss. 1-2, 2014-05 ,pp. : 155-160

Springer Publishing Company

Access to resources Recommend Favorite

Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients

By Jiang Min   Zhang Peng   Hu Guozhu   Xiao Zuke   Xu Fanghua   Zhong Ting   Huang Fang   Kuang Haibin   Zhang Wei  

Molecular and Cellular Biochemistry, Vol. 383, Iss. 1-2, 2013-11 ,pp. : 67-75

Springer Publishing Company

Access to resources Recommend Favorite

Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer

By Chen Chi-qi   Chen Cheng-shui   Chen Jun-jie   Zhou Lian-ping   Xu Hong-lei   Jin Wei-wei   Wu Jian-bo   Gao Shen-meng  

Molecular and Cellular Biochemistry, Vol. 383, Iss. 1-2, 2013-11 ,pp. : 137-148

Springer Publishing Company

Access to resources Recommend Favorite

The clinical value of miR‐193a‐3p in non‐small cell lung cancer and its potential molecular mechanism explored in silico using RNA‐sequencing and microarray data

By  

FEBS Open Bio, Vol. 8, Iss. 1, 2018-01 ,pp. : 94-109

John Wiley & Sons Inc

Access to resources Recommend Favorite